Trial intelligence / Profile preview

Remimazolam + etomidate vs propofol for painless gastroscopy in elderly patients

ChiCTR2400081696Phase 4Completed

Sponsor
The First Affiliated Hospital of Shihezi University
Start
Mar 2024
Modality
Small Molecules
Countries
1
01

Overview

Phase 4, randomised trial in None comparing Remimazolam + etomidate with Propofol (2 arms). Primary endpoints: blood pressure, heart rate and 1 more. Started Mar 2024; status: completed.

02

Drugs

remimazolametomidatepropofol

Beyond the preview

Go deeper on ChiCTR2400081696.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on ChiCTR2400081696.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call